Johnson & Johnson's medical device business shrunk by 32.7% in the second quarter of 2020 due to the COVID-19 pandemic, but the company's management remains optimistic that procedure volumes will recover by the end of the year.
Total revenues for J&J’s devices businesses were $4.3bn during the second quarter. By comparison, J&J’s medical device revenues declined by...






